Unknown

Dataset Information

0

TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.


ABSTRACT: TEM-28 (pI 6.1), expressed by an Escherichia coli clinical isolate, is a novel beta-lactamase which hydrolyzed ceftazidime, cefotaxime, and aztreonam with rates of 25, 1.1, and 5.6, respectively, relative to that for benzylpenicillin (100). The nucleotide sequence of blaTEM-28 differed from that of blaTEM-1 by two base changes, resulting in amino acid substitutions of Arg-164 to His and Glu-240 to Lys.

SUBMITTER: Bradford PA 

PROVIDER: S-EPMC163097 | biostudies-other | 1996 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.

Bradford P A PA   Jacobus N V NV   Bhachech N N   Bush K K  

Antimicrobial agents and chemotherapy 19960101 1


TEM-28 (pI 6.1), expressed by an Escherichia coli clinical isolate, is a novel beta-lactamase which hydrolyzed ceftazidime, cefotaxime, and aztreonam with rates of 25, 1.1, and 5.6, respectively, relative to that for benzylpenicillin (100). The nucleotide sequence of blaTEM-28 differed from that of blaTEM-1 by two base changes, resulting in amino acid substitutions of Arg-164 to His and Glu-240 to Lys. ...[more]

Similar Datasets

| S-EPMC2151416 | biostudies-literature
| S-EPMC90891 | biostudies-literature
| S-EPMC89239 | biostudies-literature
| S-EPMC166109 | biostudies-literature
| S-EPMC1068604 | biostudies-literature
| S-EPMC1087658 | biostudies-literature
| S-EPMC3032993 | biostudies-literature
| S-EPMC3586863 | biostudies-literature
| S-EPMC3232759 | biostudies-literature
| S-EPMC4350043 | biostudies-literature